Quick Research
Filters Clear All
Any Time
- 2026
- 2025
- 2024
- 2023
- 2022
- 2021
- 2020
- 2019
- 2018
- 2017
- 2016
- 2015
- 2014
Product Category
- Cell Culture Medium
- Cell Culture Reagent
- Cell Function Assay
- Cell Health Detection Kit
- Cell Line
- Others
- Primary Cell
- Serum
- Service
- Transfection Reagent
Country
- Argentina
- Australia
- Austria
- Bangladesh
- Barbados
- Belarus
- Belgium
- Brazil
- Bulgaria
- Burkina Faso
- Cambodia
- Cameroon
- Canada
- Chile
- China
- Chinese Taiwan
- Croatia
- Cyprus
- Czech
- Czechia
- Denmark
- Egypt
- Estonia
- Ethiopia
- Finland
- France
- Gabon
- Germany
- Ghana
- Greece
- Guyana
- Hungary
- India
- Iran
- Ireland
- Israel
- Italy
- Japan
- Kenya
- Korea
- Kuwait
- Luxembourg
- Madagascar
- Malaysia
- Mexico
- Mongolia
- Morocco
- Mozambique
- Myanmar
- Nepal
- Netherlands
- New Zealand
- Niger
- Nigeria
- Norway
- Pakistan
- Philippines
- Poland
- Portugal
- Romania
- Russia
- Russian Federation
- Saudi Arabia
- Singapore
- Slovenia
- Somalia
- South Africa
- South Korea
- Spain
- Sri Lanka
- Sudan
- Sweden
- Switzerland
- Syria
- Thailand
- Tunisia
- Turkey
- UAE
- UK
- USA
- Uganda
- Ukraine
- United Arab Emirates
- United Kingdom
- Uruguay
- Uzbekistan
- Vietnam
Publications
Procell has assisted our customers in publishing 27,713 papers in SCI-indexed journals, including leading journals such as Nature Medicine, Nature, Cell, Science, and Signal Transduction and Targeted Therapy.
Filter
-
Targeting Siglec-15 mediates mitochondrial retrograde regulation of cervical cancer development (2024-12-31)
Journal: TISSUE & CELL (2024) IF: 2.7Products Cited: C-33 A Cells Line, Human Cervical Epithelial Cells, Hela Cells Line, SiHa Cells Line -
KPNA2/KPNB1 promotes the malignant progression of gastric cancer induced by M2 macrophage polarization (2024-12-31)
Journal: TISSUE & CELL (2024) IF: 2.7Products Cited: MFC Cells Line, DMEM (High glucose) Complete Medium (10), RPMI-1640 Medium -
Stereotactic body radiation therapy suppresses myeloid-derived suppressor cells by regulating miR-21/Sorbin and SH3 Domain-containing Protein 1 axis (2024-06-14)
Journal: HUMAN & EXPERIMENTAL TOXICOLOGY (2024) IF: 2.7Products Cited: 100 mM Sodium Pyruvate Solution, 100 ×, IL-6/IFN-β2/BSF-2, Human, Recombinant, Fetal Bovine Serum, GM-CSF/CSF2 (C-6His), Mouse, Recombinant -
Downregulation of miR-138-5p alleviates propofol-induced neurotoxicity and autophagy by regulating SIRT1 (2024-10-23)
Journal: HUMAN & EXPERIMENTAL TOXICOLOGY (2024) IF: 2.7Products Cited: DMEM (High glucose) Medium, SH-SY5Y [SHSY-5Y] Cells Line -
Protective effects of atractylenolide III on oxygen‐glucose‐deprivation/reperfusion‐induced injury in HT22 cells (2024-09-26)
Journal: HUMAN & EXPERIMENTAL TOXICOLOGY (2024) IF: 2.7Products Cited: HT22 Cells Line -
VT204: A Potential Small Molecule Inhibitor Targeting KRASG12C Mutation for Therapeutic Intervention in Non-Small Cell Lung Cancer (2024-07-25)
Journal: TECHNOLOGY IN CANCER RESEARCH & TREATMENT (2024) IF: 2.7Products Cited: A549 [A-549] Cells Line, NCI-H358 Cells Line -
LncRNA NONHSAT227443.1 Confers Esophageal Squamous Cell Carcinoma Chemotherapy Resistance by Activating PI3K/AKT Signaling via Targeting MRTFB (2024-08-16)
Journal: TECHNOLOGY IN CANCER RESEARCH & TREATMENT (2024) IF: 2.7Products Cited: STR Identification, TE-12 Cells Line, KYSE-150 Cells Line, TE-1 Cells Line -
The Antimicrobial Peptide Merecidin Inhibit the Metastasis of Triple-Negative Breast Cancer by Obstructing EMT via miR-30d-5p/Vimentin (2024-09-12)
Journal: TECHNOLOGY IN CANCER RESEARCH & TREATMENT (2024) IF: 2.7Products Cited: MDA-MB-468-06 Cells Line -
Establishment of a Prognostic Model for Pancreatic Cancer Based on Hypoxia-Related Genes (2024-10-21)
Journal: TECHNOLOGY IN CANCER RESEARCH & TREATMENT (2024) IF: 2.7Products Cited: DMEM/F12 (Glucose free) Medium, PANC-1 Cells Line -
Isolation and Characterization of Meniscus Progenitor Cells From Rat, Rabbit, Goat, and Human (2024-07-26)
Journal: Cartilage (2024) IF: 2.7
